Jennifer L Good
CIK 1229245 · President & CEO · last filed 2026-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RYTM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SANDY HOOK, CT 06482
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RYTM | Director | 11,712 | $112.28 | $1.32M | -$4.27M | 13 | 2026-06-25 |
| TRVI | President & CEO | 218,576 | $14.33 | $3.13M | -$195.5K | 19 | 2026-02-20 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 2 | 2018-08-15 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | President & CEO | 18,034 | — | — | $16.1K | 10 | 2010-09-22 |
Recent Filings · Page 5 of 5
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-28 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Exer (M) | +25,000 | $39.0K | EDGAR |
| 2010-03-08 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-12 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Buy (P) | +7,500 | $16.1K | EDGAR |
| 2009-03-09 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-18 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-12 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-04-07 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-14 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-03-02 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.